How Generative AI is Transforming Life Sciences
The future of R&D in Life Science hinges on using intelligent technologies to dramatically improve cycle times, success rates, and efficiency. A McKinsey study finds Generative AI (GenAI) could generate $60 billion to $110 billion annually in economic value for pharmaceutical and medtech companies with its ability to ability to predict off-target effects, optimize drug […]
Accelerating Drug Research with AI in Clinical Trials
AI in clinical trials accelerates drug discovery by streamlining data analysis, predicting patient outcomes, and segregating cohort for trial.
Gleecus Visit to AWS re:Invent 2023, VigeoDash, and ValidationMaster Headquarters
Gleecus TechLabs Inc. recently attended the AWS re:Invent 2023 in Las Vegas and also caught up with prominent clients, VigeoDash and ValidationMaster